Cargando…
Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
Autores principales: | Zhang, Ruiqi, Mamza, Jil Billy, Morris, Tamsin, Godfrey, George, Asselbergs, Folkert W., Denaxas, Spiros, Hemingway, Harry, Banerjee, Amitava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941726/ https://www.ncbi.nlm.nih.gov/pubmed/35317796 http://dx.doi.org/10.1186/s12916-022-02308-1 |
Ejemplares similares
-
Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
por: Zhang, Ruiqi, et al.
Publicado: (2022) -
Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals
por: Dashtban, Ashkan, et al.
Publicado: (2023) -
Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
por: Idris, Iskandar, et al.
Publicado: (2021) -
A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease
por: Dashtban, Ashkan, et al.
Publicado: (2022) -
Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study
por: Pasea, Laura, et al.
Publicado: (2023)